Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), is a particularly devastating cancer commonly diagnosed in women in their twenties and often has a very poor prognosis. In a recent study, researchers with the BC Cancer Research Institute have uncovered a metabolic vulnerability present in SCCOHT cells which may be a target for future treatment options.
The Lymphoma Research Foundation (LRF) is the largest non-profit lymphoma research organization in North America with a volunteer scientific advisory board comprised of world-renowned lymphoma experts, including Dr. David Scott. Dr. Scott is the clinical director of the BC Cancer Centre for Lymphoid Cancer, deputy head of the BC Cancer Lymphoid Cancer Research and an associate professor at the University of British Columbia. Dr.
Today the American Association for Cancer Research (AACR) has awarded teams associated with The Cancer Genome Atlas (TCGA)—including three researchers from Canada’s Michael Smith Genome Sciences Centre (GSC) at BC Cancer—with a 2020 AACR team science award.
Gillian Carleton is no stranger to hard work. The BC Cancer researcher, University of Victoria student and Team Canada Olympic medalist can now include a Vanier Canada Scholarship award under their belt. The award is arguably one of the most prestigious graduate scholarship awards in Canada, offering recipients $50,000 per year for 3 years while they finish their graduate studies.
The new test will be able to better diagnose different types of ovarian cancer, a tool that could one day guide and improve treatment options for patients.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.